Ss. Winter et al., TUMOR-NECROSIS-FACTOR-ALPHA SUPPRESSES HEMATOPOIESIS IN CHILDREN WITHMYELODYSPLASIA, Medical and pediatric oncology, 28(1), 1997, pp. 69-74
The term myelodysplasia (MDS) refers to a group of bone marrow failure
syndromes which are relatively rare in childhood. The pathogenesis of
MDS is unknown, but a variety of chromosomal, molecular, and cytochem
ical abnormalities have been reported. We describe a 4-month old femal
e with MDS who presented with severe neutropenia and refractory anemia
with excess blasts (RAEB). Bone marrow progenitor cell assays showed
decreased erythroid and myeloid colony formation as compared to normal
marrow, and the patient's serum further diminished colony formation o
f both her own and control marrow. These observations suggested the pr
esence of a soluble factor inhibitory to hematopoiesis. Reverse transc
riptase-polymerase chain reaction (RT-PCR) analysis of total RNA deriv
ed from the patient's bone marrow mononuclear cells revealed highly el
evated tumor necrosis factor-alpha (TNF-alpha) mRNA levels. Using a si
milar RT-PCR profile, TNF-alpha mRNA levels were found to be elevated
in two other children with myelodysplasia. We conclude that TNF-alpha
is produced in large amounts by bone marrow mononuclear cells or child
ren with MDS, and we hypothesize that TNF-alpha plays an important rol
e in the pathophysiology oi the ineffective hematopoiesis observed in
MDS. (C) 1997 Wiley-Liss, Inc.